HELP - Latest News
Helus Pharma Inc. (HELP), operates in Healthcare / Medical - Pharmaceuticals, trades on NASDAQ.
Market capitalization stands near $643.4M. Beta to the broader market is 0.54.
The article list below shows the most recent HELP headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent HELP Headlines
Helus Pharma Appoints Dr. Suresh Durgam to Board of Directors
globenewswire.com - Oct 15, 2026
This news release constitutes a “designated news release” for the purpose of the Company's prospectus supplement dated December 30, 2025, to its short
Helus Pharma: A Buy Ahead Of The HLP003 Phase 3 Readout
seekingalpha.com - Oct 11, 2026
Helus Pharma remains a buy, as HLP003's Phase 3 APPROACH topline data in 4Q26 is the key near-term catalyst. HLP003 targets adjunctive MDD with a dif
Helus Pharma to Host Investor Presentation on October 21, 2026
globenewswire.com - Oct 8, 2026
NEW YORK and TORONTO, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Helus Pharma Inc.
Helus Pharma Announces Completion of Legal Name Change
globenewswire.com - Oct 1, 2026
NEW YORK and TORONTO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP) (“Helus” or the “Company”), a clinical-stage phar
Helus Pharma Eyes Q4 Phase III Data for HLP-003 in Major Depression
marketbeat.com - Sep 24, 2026
Helus Pharma, formerly known as Cybin NASDAQ: HELP, outlined its late-stage development plans for HLP-003 in adjunctive major depressive disorder (MDD
How News Affects HELP Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track HELP's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked HELP news questions
- What is the latest HELP news headline?
- The most recent HELP headline (Oct 15, 2026) is "Helus Pharma Appoints Dr. Suresh Durgam to Board of Directors". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the HELP news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What HELP news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual HELP options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.